"BRI is an international leader in immune system and autoimmune disease research, with a focus on translating laboratory discoveries to real life applications."

During the past decade, CCOP - Virginia Mason Research Center conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 53 clinical trials were completed, i.e. on average, 171% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 19 clinical trials were completed. i.e. 158.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Virginia Mason Research Center" #1 sponsor was "SWOG Cancer Research Network" with 72 trials, followed by "Radiation Therapy Oncology Group" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 16 trials sponsored and "NSABP Foundation Inc" with 16 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Virginia Mason Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "SWOG Cancer Research Network" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 14 trials as a collaborator and "Eastern Cooperative Oncology Group" with 12 trials as a collaborator. Other collaborators include 161 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Virginia Mason Research Center" are "Breast Cancer" (31 trials), "Lung Cancer" (19 trials), "Lymphoma" (13 trials), "Colorectal Cancer" (11 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "CCOP - Virginia Mason Research Center" in a lesser frequency.

Most popular intervention types in "CCOP - Virginia Mason Research Center" are "Drug" (173 trials), "Radiation" (40 trials), "Biological" (38 trials), "Procedure" (34 trials) and "Other" (31 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (25 trials), "cyclophosphamide" (22 trials), "cisplatin" (21 trials), "Placebo" (19 trials) and "fluorouracil" (16 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Virginia Mason Research Center" are 165 trials for "All" genders, 38 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Virginia Mason Research Center". undefined are not yet recruiting, 11 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 158 completed trials in CCOP - Virginia Mason Research Center, 1 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Virginia Mason Research Center, 7 "Phase 1" clinical trials were conducted, 94 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".